Review article · 2022 · Open access

Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment

Mubin Tarannum, Juan Luis Vivero-Escoto

Advanced Drug Delivery Reviews, 187, 114357 · Published 21 May 2022 · DOI 10.1016/j.addr.2022.114357

Open PDFView at the publisherCite this paper

In brief

“Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment” is a 2022 review article by Mubin Tarannum and Juan Luis Vivero-Escoto, published in Advanced Drug Delivery Reviews. OpenAlex counts 85 citations as of 21 November 2026, which puts it in the top 3% of works published in 2022 by citations. It is open access: the full text is free to read at Advanced Drug Delivery Reviews.

Citations
85
Most cited in
2025 (33)
Field-weighted impact
1.09
References
160
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tarannum, M., & Vivero-Escoto, J. L. (2022). Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Advanced Drug Delivery Reviews, 187, 114357. https://doi.org/10.1016/j.addr.2022.114357

MLA 9

Tarannum, Mubin, and Juan Luis Vivero-Escoto. “Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.” Advanced Drug Delivery Reviews, vol. 187, 2022, p. 114357. https://doi.org/10.1016/j.addr.2022.114357.

Chicago

Tarannum, Mubin and Juan Luis Vivero-Escoto. 2022. “Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.” Advanced Drug Delivery Reviews 187: 114357. https://doi.org/10.1016/j.addr.2022.114357.

Harvard

Tarannum, M. and Vivero-Escoto, J. L. (2022) ‘Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment’, Advanced Drug Delivery Reviews, 187, p. 114357. doi:10.1016/j.addr.2022.114357.

IEEE

M. Tarannum and J. L. Vivero-Escoto, “Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment,” Advanced Drug Delivery Reviews, vol. 187, p. 114357, 2022, doi: 10.1016/j.addr.2022.114357.

BibTeX

@article{tarannum2022nanoparticle,
  title     = {{Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment}},
  author    = {Tarannum, Mubin and Vivero-Escoto, Juan Luis},
  journal   = {Advanced Drug Delivery Reviews},
  year      = {2022},
  volume    = {187},
  pages     = {114357},
  doi       = {10.1016/j.addr.2022.114357},
  url       = {https://doi.org/10.1016/j.addr.2022.114357}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202255
20231111
20242222
20253333
20261414

Its field-weighted citation impact is 1.09: it has been cited 1.09 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • nanoparticle drug delivery
  • chemoresistance
  • combination therapy
  • immunotherapy
  • desmoplastic stroma
  • tumor microenvironment remodeling
  • molecular heterogeneity

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Tarannum, M., & Vivero-Escoto, J. L. (2022). Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Advanced Drug Delivery Reviews, 187, 114357. https://doi.org/10.1016/j.addr.2022.114357

How many times has this paper been cited?

85 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Drug Delivery Reviews: sign in and open the PDF from this page.

Who wrote this paper?

Mubin Tarannum, Juan Luis Vivero-Escoto.

What is the DOI of this paper?

10.1016/j.addr.2022.114357, permanently at https://doi.org/10.1016/j.addr.2022.114357. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.